Although presbyopia is common and expected in people older than 40 years of age, its symptoms are nonspecific (blurred vision, eye strain or headache); therefore, careful consideration of differential ...

Pharmacotherapy is the newest modality of presbyopia management, with the first agent (pilocarpine) gaining FDA approval for presbyopia in 2021. It offers a local, non-invasive, and reversible ...

Experts say the findings point to a future where drops could be a first-line presbyopia treatment over glasses. "This points toward a future where drops might replace or at least reduce reliance on ...

VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition impacting approximately 128 million adults in the United States First once ...

(RTTNews) - Viatris Inc. (VTRS), a healthcare company, on Wednesday said the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for phentolamine ...